586 related articles for article (PubMed ID: 16869817)
21. Population pharmacokinetics of gentamicin in premature newborns.
García B; Barcia E; Pérez F; Molina IT
J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742
[TBL] [Abstract][Full Text] [Related]
22. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.
Allegaert K; Anderson BJ; Naulaers G; de Hoon J; Verbesselt R; Debeer A; Devlieger H; Tibboel D
Eur J Clin Pharmacol; 2004 May; 60(3):191-7. PubMed ID: 15071761
[TBL] [Abstract][Full Text] [Related]
23. The impact of ibuprofen or indomethacin on renal drug clearance in neonates.
Allegaert K
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():88-91. PubMed ID: 19701859
[TBL] [Abstract][Full Text] [Related]
24. I.V. acetaminophen pharmacokinetics in neonates after multiple doses.
Palmer GM; Atkins M; Anderson BJ; Smith KR; Culnane TJ; McNally CM; Perkins EJ; Chalkiadis GA; Hunt RW
Br J Anaesth; 2008 Oct; 101(4):523-30. PubMed ID: 18628265
[TBL] [Abstract][Full Text] [Related]
25. Actual body weight-based vancomycin dosing in neonates.
Pokorná P; Šíma M; Černá O; Allegaert K; Tibboel D; Slanař O
J Chemother; 2019 Oct; 31(6):307-312. PubMed ID: 30983533
[TBL] [Abstract][Full Text] [Related]
26. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
[TBL] [Abstract][Full Text] [Related]
27. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.
Anderson BJ; van Lingen RA; Hansen TG; Lin YC; Holford NH
Anesthesiology; 2002 Jun; 96(6):1336-45. PubMed ID: 12170045
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation.
Sandra L; Smits A; Allegaert K; Nicolaï J; Annaert P; Bouillon T
Br J Clin Pharmacol; 2021 Apr; 87(4):2089-2097. PubMed ID: 33085795
[TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Kimura T; Sunakawa K; Matsuura N; Kubo H; Shimada S; Yago K
Antimicrob Agents Chemother; 2004 Apr; 48(4):1159-67. PubMed ID: 15047516
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetics of vancomycin in the neonate: a review.
Pacifici GM; Allegaert K
Clinics (Sao Paulo); 2012 Jul; 67(7):831-7. PubMed ID: 22892931
[TBL] [Abstract][Full Text] [Related]
32. Clonidine disposition in children; a population analysis.
Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
[TBL] [Abstract][Full Text] [Related]
33. The influences of renal function and maturation on vancomycin elimination in newborns and infants.
Capparelli EV; Lane JR; Romanowski GL; McFeely EJ; Murray W; Sousa P; Kildoo C; Connor JD
J Clin Pharmacol; 2001 Sep; 41(9):927-34. PubMed ID: 11549096
[TBL] [Abstract][Full Text] [Related]
34. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
35. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
[TBL] [Abstract][Full Text] [Related]
36. A target concentration strategy to determine ibuprofen dosing in children.
Anderson BJ; Hannam JA
Paediatr Anaesth; 2019 Nov; 29(11):1107-1113. PubMed ID: 31472084
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
39. Predicting weight using postmenstrual age--neonates to adults.
Sumpter AL; Holford NH
Paediatr Anaesth; 2011 Mar; 21(3):309-15. PubMed ID: 21320235
[TBL] [Abstract][Full Text] [Related]
40. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I; Kirkpatrick C; Holford N
Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
